Neopharma snatches Dr. Reddy's API business as it continues global expansion
admin 15th October 2018 Uncategorised 0Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business to the Middle East-based Neopharma. The move comes as the Indian drugmaker continues to cut costs and Neopharma makes moves to become a player in western drug making.
More: Neopharma snatches Dr. Reddy's API business as it continues global expansion
Source: fierce